3rd International Conference on Influenza and Zoonotic Diseases August 21-22, 2017 Birmingham, UK- C1: How the C1 platform will change the production approach for recombinant vaccines
proven itself, commercially and scientifically, as a high quality and highly productive producer of enzymes and proteins using a proprietary and patented expression system based on the Myceliophtho ra thermophila…

